- Adherence among chronic disease patients can lead to big savings
- FDA approves Merck's Gardasil for prevention of anal cancer
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Walgreens launches high-impact push in support of World AIDS Day campaign
SANTA ANA, Calif. — Robinson Pharma last week introduced its Unique IS-2 Probiotic Softgel in collaboration with B&D Nutritional Ingredients and Unique Biotech USA. The new product is a shelf-stable, guaranteed-yield probiotic softgel that delivers the Unique IS-2 Bacillus coagulans strain, a trademarked bacterium which has demonstrated high resistance to extreme temperature and humidity.
Probiotics are a hot business, Robinson Pharma stated in a release. "Probiotics are, and will continue to be, one of the most exciting categories in the supplement and foods industries," the company stated. "The massive growth in category sales and well developed consumer awareness is driven by a strong pedigree of clinical research supporting manifold benefits. RPI recognized more than a year ago that the category lacked an easy to swallow, soft gelatin capsule of a documented and researched strain offering a guaranteed shelf life. Filling this key market niche’ was the goal of our program."
B&D Nutritional Ingredients, the exclusive U.S. distributor of Unique IS-2 and Robinson Pharma signed an exclusive agreement for the production and sale of soft gelatin capsules containing this strain. Robinson Pharma has initiated marketing of the product and forecasts a market introduction later this year.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.